Correlation Between Akero Therapeutics and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Cardiff Oncology, you can compare the effects of market volatilities on Akero Therapeutics and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Cardiff Oncology.
Diversification Opportunities for Akero Therapeutics and Cardiff Oncology
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akero and Cardiff is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Cardiff Oncology
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.95 times less return on investment than Cardiff Oncology. But when comparing it to its historical volatility, Akero Therapeutics is 1.84 times less risky than Cardiff Oncology. It trades about 0.07 of its potential returns per unit of risk. Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Cardiff Oncology on September 4, 2024 and sell it today you would earn a total of 131.00 from holding Cardiff Oncology or generate 102.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Cardiff Oncology
Performance |
| Timeline |
| Akero Therapeutics |
| Cardiff Oncology |
Akero Therapeutics and Cardiff Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Cardiff Oncology
The main advantage of trading using opposite Akero Therapeutics and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets |